Regencell Bioscience Holdings (Regencell Bioscience Holdings) Price-to-Tangible-Book

: 5.65 (As of Today)

View and export this data going back to 2021. Start your Free Trial

As of today (2024-04-18), Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $0.92. Hence, Regencell Bioscience Holdings's Price to Tangible Book Ratio of today is 5.65.

The historical rank and industry rank for Regencell Bioscience Holdings's Price-to-Tangible-Book or its related term are showing as below:

RGC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.13 Med: 25.67 Max: 26.4
Current: 5.67

During the past 5 years, Regencell Bioscience Holdings's highest Price to Tangible Book Ratio was 26.40. The lowest was 5.13. And the median was 25.67.

RGC's Price-to-Tangible-Book is ranked worse than
79.82% of 872 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs RGC: 5.67

A closely related ratio is called PB Ratio. As of today, Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings's Book Value per Sharefor the quarter that ended in Jun. 2023 was $0.92. Hence, Regencell Bioscience Holdings's P/B Ratio of today is 5.65.

Regencell Bioscience Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Regencell Bioscience Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

26.40

24.94

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book					-	20.97	26.40	24.77	24.94

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Price-to-Tangible-Book falls into.

Regencell Bioscience Holdings Price-to-Tangible-Book Calculation

Regencell Bioscience Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	5.22	/	0.924
	=	5.65

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Regencell Bioscience Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.